Atlas Trials

Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes

Clinical trial NCT01586442 · COMPLETED

Trial details

NCT number
NCT01586442
Sponsor
Montreal Heart Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Heart FailureType 2 DiabetesGlucose Intolerance
Start date
2012-03-01
Primary completion
2015-03-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.